Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines

SARS-CoV-2 vaccination has been recommended for liver transplant (LT) recipients. However, our understanding of inactivated vaccine stimulation of the immune system in regulating humoral and cellular immunity among LT recipients is inadequate. Forty-six LT recipients who received two-dose inactivate...

Full description

Bibliographic Details
Main Authors:	Binwei Duan, Gongming Zhang, Wenjing Wang, Jiming Yin, Mengcheng Liu, Jing Zhang, Dexi Chen, Yabo Ouyang, Guangming Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 inactivated vaccines liver transplant recipient neutralizing antibodies CD3+ CD19+ cell CXCL10
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.954177/full

Similar Items

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
by: Yufei Wu, et al.
Published: (2023-07-01)

Dynamics of CD4+ T-Cells and Neutralizing Antibody Responses to Three Consecutive Doses of Inactivated COVID-19 Vaccines in PLWH
by: Zhang W, et al.
Published: (2023-05-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
by: Juan Li, et al.
Published: (2021-10-01)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
by: Songjie Wu, et al.
Published: (2023-01-01)

Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine
by: Chan Wang, et al.
Published: (2022-12-01)

Radiation-Inactivated S. gallinarum Vaccine Provides a High Protective Immune Response by Activating Both Humoral and Cellular Immunity
by: Hyun Jung Ji, et al.
Published: (2021-08-01)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
by: Lei Zhang, et al.
Published: (2023-01-01)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
by: Yaping Chen, et al.
Published: (2022-12-01)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
by: Wei M, et al.
Published: (2020-01-01)

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −11
by: Yixi Su, et al.
Published: (2024-04-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

Enhanced Immunogenicity of Inactivated Dengue Vaccines by Novel Polysaccharide-Based Adjuvants in Mice
by: Shuenn-Jue Wu, et al.
Published: (2022-05-01)

Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis
by: Guihua Tang, et al.
Published: (2018-11-01)

Preparation and evaluation of goose reovirus inactivated vaccine
by: Xiaoyu Niu, et al.
Published: (2017-07-01)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
by: Huiqiong Zeng, et al.
Published: (2022-11-01)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
by: Tong Li, et al.
Published: (2022-09-01)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
by: Yan Zhou, et al.
Published: (2023-01-01)

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models
by: Ze-Jun Wang, et al.
Published: (2020-01-01)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
by: Maryam Keshtkar-Jahromi, et al.
Published: (2020-11-01)

Immunogenicity and protective efficacy of OmpA subunit vaccine against Aeromonas hydrophila infection in Megalobrama amblycephala: An effective alternative to the inactivated vaccine
by: Minying Zhang, et al.
Published: (2023-03-01)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
by: Shuyu Gao, et al.
Published: (2022-11-01)

Immunogenicity of COVID-19 vaccination in kidney transplant recipients
by: V S Jibia, et al.
Published: (2023-01-01)

Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2024-01-01)

Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy
by: Pilar Jiménez, et al.
Published: (2011-04-01)

Immune responses to an inactivated Johne’s disease vaccine in cattle
by: R K CHAITANYA, et al.
Published: (2022-10-01)

Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice
by: Seo Yeon Kim, et al.
Published: (2024-03-01)

Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China
by: Xia Feng, et al.
Published: (2021-03-01)

Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine
by: Chuan-Yu He, et al.
Published: (2022-04-01)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022-11-01)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
by: Han X, et al.
Published: (2022-04-01)

Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
by: Wenhao Ouyang, et al.
Published: (2024-03-01)

30-Year Development of Inactivated Virus Vaccine in China
by: Jinrong Shi, et al.
Published: (2023-12-01)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
by: Lin Y, et al.
Published: (2019-10-01)

Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China
by: Xiaodong Liu, et al.
Published: (2022-06-01)

Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants
by: Yuntao Zhang, et al.
Published: (2022-06-01)

COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
by: M. I Chernikova, et al.
Published: (2015-12-01)

Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune Responses
by: Yuanling Bao, et al.
Published: (2020-12-01)

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
by: Shu-Hsing Cheng, et al.
Published: (2022-12-01)

CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ
by: Frederick Allen, et al.
Published: (2018-03-01)

Neutralization Effect of Sera against Delta and Omicron in Patients Recovering from COVID-19 and Inactivated Vaccine Recipients
by: Yajuan Zhu, et al.
Published: (2023-02-01)